![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 44, 41571-41579, November 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
From the Departments of Urokinase-type plasminogen activator (uPA)
is a member of the serine protease family and can break down various
components of the extracellular matrix to promote growth, invasion, and
metastasis of several malignancies including breast cancer. In the
current study we examined the role that the DNA methylation machinery might be playing in regulating differential uPA gene expression in
breast cancer cell lines. uPA mRNA is expressed in the highly invasive, hormone-insensitive human breast cancer cell line MDA-MB-231 but not in hormone-responsive cell line MCF-7. Using
methylation-sensitive PCR, we show that 90% of CpG
dinucleotides in the uPA promoter are methylated in MCF-7 cells,
whereas fully demethylated CpGs were detected in MDA-MB-231 cells. uPA
promoter activity, which is directly regulated by the Ets-1
transcription factor, is inhibited by methylation as determined by uPA
promoter-luciferase reporter assays. We then tested whether the state
of expression and methylation of the uPA promoter correlates with the
global level of DNA methyltransferase and demethylase activities in
these cell lines. We show that maintenance DNA methyltransferase
activity is significantly higher in MCF-7 cells than in MDA-MB-231
cells, whereas demethylase activity is higher in MDA-MB-231 cells. We
suggest that the combination of increased DNA methyltransferase
activity with reduced demethylase activity contributes to the
methylation and silencing of uPA expression in MCF-7 cells. The
converse is true in MDA-MB-231 cells, which represents a late stage
highly invasive breast cancer. The histone deacetylase inhibitor,
Trichostatin A, induces the expression of the uPA gene in MDA-MB-231
cells but not in MCF-7 cells. This supports the hypothesis that DNA
methylation is the dominant mechanism involved in the silencing of uPA
gene expression. Taken together, these results provide insight into the
mechanism regulating the transcription of the uPA gene in the complex
multistep process of breast cancer progression.
Medicine and
¶ Pharmacology, McGill University Health Center, Montreal,
Quebec H3A 1A1, Canada
To whom correspondence should be addressed: McGill University
Health Center, 687 Pine Ave. W., Rm. H4.67, Montreal, Quebec H3A 1A1,
Canada. Tel.: 514-843-1632; Fax: 514-843-1712; E-mail: srabbani@med.mcgill.ca.
This article has been cited by other articles:
![]() |
S. M. K. Pulukuri, B. Gorantla, and J. S. Rao Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator J. Biol. Chem., December 7, 2007; 282(49): 35594 - 35603. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Matteucci, E. Ridolfi, P. Maroni, P. Bendinelli, and M. A. Desiderio c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells Mol. Cancer Res., August 1, 2007; 5(8): 833 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wischnewski, O. Friese, K. Pantel, and H. Schwarzenbach Methyl-CpG Binding Domain Proteins and Their Involvement in the Regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 Gene Promoters Mol. Cancer Res., July 1, 2007; 5(7): 749 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milutinovic, A. C. D'Alessio, N. Detich, and M. Szyf Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes Carcinogenesis, March 1, 2007; 28(3): 560 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maroni, P. Bendinelli, E. Matteucci, and M. A. Desiderio HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-{kappa}B Carcinogenesis, February 1, 2007; 28(2): 267 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S Perry, R. Foley, K. Woodson, and M. Lawler The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wischnewski, K. Pantel, and H. Schwarzenbach Promoter Demethylation and Histone Acetylation Mediate Gene Expression of MAGE-A1, -A2, -A3, and -A12 in Human Cancer Cells Mol. Cancer Res., May 1, 2006; 4(5): 339 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kishimoto, Z. Wang, P. Bhat-Nakshatri, D. Chang, R. Clarke, and H. Nakshatri The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1{alpha}/CXCL12 Carcinogenesis, October 1, 2005; 26(10): 1706 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tokizane, H. Shiina, M. Igawa, H. Enokida, S. Urakami, T. Kawakami, T. Ogishima, S. T. Okino, L.-C. Li, Y. Tanaka, et al. Cytochrome P450 1B1 Is Overexpressed and Regulated by Hypomethylation in Prostate Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5793 - 5801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Paredes, A. Albergaria, J. T. Oliveira, C. Jeronimo, F. Milanezi, and F. C. Schmitt P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation Clin. Cancer Res., August 15, 2005; 11(16): 5869 - 5877. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pakneshan, M. Szyf, and S. A. Rabbani Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells Carcinogenesis, March 1, 2005; 26(3): 557 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogishima, H. Shiina, J. E. Breault, L. Tabatabai, W. W. Bassett, H. Enokida, L.-C. Li, T. Kawakami, S. Urakami, L. A. Ribeiro-Filho, et al. Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1028 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pakneshan, M. Szyf, R. Farias-Eisner, and S. A. Rabbani Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis J. Biol. Chem., July 23, 2004; 279(30): 31735 - 31744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milutinovic, S. E. Brown, Q. Zhuang, and M. Szyf DNA Methyltransferase 1 Knock Down Induces Gene Expression by a Mechanism Independent of DNA Methylation and Histone Deacetylation J. Biol. Chem., July 2, 2004; 279(27): 27915 - 27927. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pakneshan, B. Tetu, and S. A. Rabbani Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3035 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, H. Kishimoto, H. L. Chua, S. Badve, K. D. Miller, R. M. Bigsby, and H. Nakshatri Interleukin-1{alpha} Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer Am. J. Pathol., December 1, 2003; 163(6): 2531 - 2541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hermann, S. Schmitt, and A. Jeltsch The Human Dnmt2 Has Residual DNA-(Cytosine-C5) Methyltransferase Activity J. Biol. Chem., August 22, 2003; 278(34): 31717 - 31721. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feldman, V. I. Sementchenko, M. Gayed, M. M. Fraig, and D. K. Watson Pdef Expression in Human Breast Cancer Is Correlated with Invasive Potential and Altered Gene Expression Cancer Res., August 1, 2003; 63(15): 4626 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Chen, H.-L. Chen, T. H.-C. Hsiau, A. H.-A. Hsiau, H. Shi, G. J. R. Brock, S. H. Wei, C. W. Caldwell, P. S. Yan, and T. H.-M. Huang Methylation Target Array for Rapid Analysis of CpG Island Hypermethylation in Multiple Tissue Genomes Am. J. Pathol., July 1, 2003; 163(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |